Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of enteric-coated mycophenolate sodium in kidney transplant recipients with delayed graft function
ChiCTR2400086180Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate sodium in Kidney allograft status (RTx) and kidney transplant immunosuppression (2 arms), sponsored by Renji Hospital. Primary endpoint: MPA-AUC0-12h. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
Kidney allograft status (RTx)kidney transplant immunosuppression
Beyond the preview
Go deeper on ChiCTR2400086180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086180.